World Health Organization, August 1, 2018 The WHO PrEP Implementation Tool App for Health Workers App is now available. On-the-go access to the following modules from the WHO PrEP Implementation Tool: Clinical: for clinicians, including physicians, nurses and clinical officers Counsellors: for staff who counsel people as they consider or start taking PrEP, and support them in coping with side...
UAB Medicine News, 23.04.18 The Academy of Nutrition and Dietetics released their new guidelines for medical nutrition therapy in HIV care titled “Practice Paper of the Academy of Nutrition and Dietetics: Nutrition Intervention and Human Immunodeficiency Virus Infection,” with Amanda Willig, Ph.D., R.D., assistant professor in the University of Alabama at Birmingham Division of Infectious...
ABC 730 report, 26/3/2018 A steady stream of Australian women with pelvic mesh implants have spent tens of thousands of dollars flying to a clinic in Missouri to have their implants removed, claiming they have suffered major side-effects from the implants used to treat prolapse and incontinence. More than 35 Australian women have made the journey to the same practitioner because, they say, they...
SHINE SA, October 2017 This dynamic 3-day course aims to update workers to include relationships and sexual health education and support in their work. On completion of the FRESH Course you will have:side • an increased level of confidence working with people in the area of sexual health and relationships • a better understanding of how values and beliefs may influence your practice in this area...
ABC Health & Wellbeing, Sunday at 08:08 While it’s hard to know exactly how many women experience low libido, it seems it might be more common than previously thought. Almost 70 per cent of Australian women aged 40-65 years old reported a lack of sexual desire in a recent study published in the Journal of Sexual Medicine. The authors noted this was “somewhat higher” than...
Journal of Virus Eradication, 2017; 3: 168–184 Daily use of co-formulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine‘s...